Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 1
2010 1
2011 5
2012 4
2013 2
2014 1
2015 4
2016 3
2017 4
2018 3
2019 7
2020 3
2021 2
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Suppressor Analysis in CML.
Herrmann O, Schemionek M. Herrmann O, et al. Among authors: schemionek m. Methods Mol Biol. 2016;1465:87-94. doi: 10.1007/978-1-4939-4011-0_8. Methods Mol Biol. 2016. PMID: 27581141
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients.
Jacobi H, Vieri M, Bütow M, Namasu CY, Flüter L, Costa IG, Maié T, Lindemann-Docter K, Chatain N, Beier F, Huber M, Wagner W, Crysandt M, Brümmendorf TH, Schemionek M. Jacobi H, et al. Among authors: schemionek m. Front Pharmacol. 2023 Jul 4;14:1212392. doi: 10.3389/fphar.2023.1212392. eCollection 2023. Front Pharmacol. 2023. PMID: 37469867 Free PMC article.
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling.
Kuepper MK, Bütow M, Herrmann O, Ziemons J, Chatain N, Maurer A, Kirschner M, Maié T, Costa IG, Eschweiler J, Koschmieder S, Brümmendorf TH, Müller-Newen G, Schemionek M. Kuepper MK, et al. Among authors: schemionek m. Leukemia. 2019 Aug;33(8):1964-1977. doi: 10.1038/s41375-019-0427-7. Epub 2019 Mar 6. Leukemia. 2019. PMID: 30842608
Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita.
Kirschner M, Maurer A, Wlodarski MW, Ventura Ferreira MS, Bouillon AS, Halfmeyer I, Blau W, Kreuter M, Rosewich M, Corbacioglu S, Beck J, Schwarz M, Bittenbring J, Radsak MP, Wilk CM, Koschmieder S, Begemann M, Kurth I, Schemionek M, Brümmendorf TH, Beier F. Kirschner M, et al. Among authors: schemionek m. Leukemia. 2018 Aug;32(8):1762-1767. doi: 10.1038/s41375-018-0125-x. Epub 2018 Apr 2. Leukemia. 2018. PMID: 29749397 Free article.
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma.
Metselaar J, Lammers T, Boquoi A, Fenk R, Testaquadra F, Schemionek M, Kiessling F, Isfort S, Wilop S, Crysandt M. Metselaar J, et al. Among authors: schemionek m. Drug Deliv Transl Res. 2023 Apr;13(4):915-923. doi: 10.1007/s13346-022-01268-6. Epub 2023 Jan 2. Drug Deliv Transl Res. 2023. PMID: 36592287 Free PMC article. Clinical Trial.
38 results